Stock MLTX MOONLAKE IMMUNOTHERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart MoonLake Immunotherapeutics

Equities

MLTX

KY61559X1045

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-18 pm EDT 		5-day change 1st Jan Change
39.49 USD -1.69% Intraday chart for MoonLake Immunotherapeutics -9.05% -34.61%
Jun. 10 MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from Both FDA and EMA on Path for the Phase 3 Program for the Nanobody Sonelokimab in Psoriatic Arthritis CI
May. 07 MoonLake Immunotherapeutics Q1 Net Loss Widens MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MOONLAKE IMMUNOTHERAPEUTICS Stock MoonLake Immunotherapeutics
 2.48B - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.72B -
BIONTECH SE Stock BioNTech SE
 20.82B -
GENMAB A/S Stock Genmab A/S
 16.66B
  1. Stock Market
  2. Equities
  3. MLTX Stock
  4. Charts MoonLake Immunotherapeutics
  5. Sector Chart